Estrogen receptor alpha (ERα), expressed in approximately 70% of invasive breast cancer cases, functions as a steroid hormone nuclear receptor and a transcription factor that, when activated by estrogen, initiates oncogenic pathways in breast cancer cells. Here, ESR1 is linked to invasive breast carcinoma.